LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Ameritas Investment Partners, Inc.'s Holding History (CIK: 0001055980)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 17,114 Value ($000) $9 Avg Close — Range —
Q4 2024
Shares 17,114 Value ($000) $11 Avg Close — Range —
Q3 2024
Shares 17,114 Value ($000) $24 Avg Close — Range —
Q2 2024
Shares 17,114 Value ($000) $25 Avg Close — Range —
Q1 2024
Shares 17,114 Value ($000) $38 Avg Close — Range —
Q4 2023
Shares 17,114 Value ($000) $33 Avg Close — Range —
Q3 2023
Shares 17,114 Value ($000) $25 Avg Close — Range —
Q2 2023
Shares 12,976 Value ($000) $41 Avg Close — Range —
Q1 2023
Shares 12,976 Value ($000) $31 Avg Close — Range —
Q4 2022
Shares 12,976 Value ($000) $39 Avg Close — Range —
Q3 2022
Shares 12,976 Value ($000) $95 Avg Close — Range —
Q2 2022
Shares 12,976 Value ($000) $84 Avg Close — Range —
Q1 2022
Shares 11,504 Value ($000) $58 Avg Close — Range —
Q4 2021
Shares 1,811 Value ($000) $14 Avg Close — Range —
Q3 2021
Shares 1,811 Value ($000) $27 Avg Close — Range —